These are the only four companies that reported sales growth of at least 10 percent in each of the last 3 quarters of the calendar year 2018, according to data compiled by ACE Equity.
Bliss GVS Pharma had posted a profit of Rs 33.98 crore in the same period a year ago.
Joindre Capital is bullish on Bliss GVS Pharma has recommended buy rating on the stock with a target price of Rs 350 in its research report dated January 09, 2018.
The 10,150-10,120 levels will remain crucial support and a fall below the 10,100 mark, can drag the index towards 10,000 level on the back of further selling.
Mitessh Thakkar of mitesshthakkar.com suggests selling Indo Count Industries, KPIT Technologies and Reliance Power and advises buying NIIT Technologies and Bliss GVS Pharma.
Jay Thakkar of Sharekhan advises buying Bliss GVS Pharma with a target of Rs 187.
Ashwani Gujral of ashwanigujral.com suggests accumulating Delta Corp and advises looking at HCL Infosystems while he feels that Sobha looks good.
Ashwani Gujral of ashwanigujral.com is of the view that Avenue Supermarts is a decent buy even at the current level.
Jay Thakkar of Anand Rathi is of the view that one may buy Bharti Infratel with a target of Rs 323.
Jay Thakkar of Sharekhan is of the view that one may buy Anant Raj with a target of Rs 45.40.
Ashish Kyal of Waves Strategy Advisors is of the view that one may buy TVS Motor Company with a target of Rs 425.
SP Tulsian of sptulsian.com shares his rationale behind his bullish view on Crompton Greaves, Motherson Sumi and Bharat Forge.
"Bliss GVS Healthcare, the Kenyan step down subsidiary of the company has won a three-year contract worth USD 111.40 million from Aon Kenya Insurance Brokers Ltd for provision of medical healthcare services in Kenya," Bliss GVS Pharma said in a BSE filing.
Bliss GVS Healthcare, a subsidiary of company, has won a 3 year contract worth USD 111.40 million from Aon Kenya Insurance Brokers for provision of medical healthcare services in Kenya.
In an interview with CNBC-TV18, market expert SP Tulsian gave his stock picks for the day and shared his market outlook.
Maruti Suzuki | HUL | Sun Pharma | Hero Motocorp | Dr Reddy's Labs | Exide Industries | Forbes & Company | Torrent Pharma | JK Lakshmi | Excel Corp | Thomas Cook | Indian Hume Pipe | Raymond | State Bank of Travancore | Religare Enterprises | Motilal Oswal | Smartlink Network | Infibeam and NBCC are stocks, which are in the news today.
Ashwani Gujral of ashwanigujral.com advises buying Mahindra and Mahindra Financial Services and suggests selling Axis Bank and Dewan Housing Finance Corporation.
SP Tulsian of sptulsian.com shares why he is bullish on Globus Spirit and Radico Khaitan. He also runs through key highlights of the Reliance Communications AGM and lists two drug stocks he is interested in.
Bliss GVS Pharma has reported a consolidated total income from operations of Rs 140.14 crore and a net profit of Rs 20.65 crore for the quarter ended Jun '16
Bharti Airtel | PNB | Sun Pharma | Tata Steel | Asian Paints | NHPC | L&T Infotech | MOIL | Mahindra & Mahindra | Torrent Pharma | Lumax Auto | Sagar Cements | Everest Industries and Indian Hume Pipe are stocks, which are in the news today.
Manish Sharma of derivativetradingresearch.com advises selling TCS with a target of Rs 2370.